Literature DB >> 18777481

Treatment of status epilepticus.

Hiba Arif1, Lawrence J Hirsch.   

Abstract

Status epilepticus (SE) is a neurological emergency that requires prompt diagnosis and treatment, as delay is associated with a higher likelihood of poor response to treatment and worse outcome. Lorazepam has been well established as a first-line therapy. Subsequent steps are less established, and there are many reasonable options, including intravenous fosphenytoin, valproate, midazolam, propofol, and phenobarbital. If intravenous access is not immediately available, rectal diazepam or nasal or buccal midazolam should be given; this can also be used as out-of-hospital treatment to prevent or treat SE. For refractory SE, continuous intravenous midazolam and propofol, separately or in combination, are rapidly effective, with pentobarbital remaining the gold standard for prolonged cases. If a patient does not awaken after treatment, urgent electroencephalogram (EEG) should be obtained to rule out nonconvulsive seizure activity. In refractory SE, continuous EEG monitoring is required to recognize recurrence of seizure activity, as most seizures will be nonconvulsive.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777481     DOI: 10.1055/s-2008-1079339

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  9 in total

Review 1.  The standardization debate: A conflation trap in critical care electroencephalography.

Authors:  Marcus C Ng; Nicolas Gaspard; Andrew J Cole; Daniel B Hoch; Sydney S Cash; Matt Bianchi; Deirdre A O'Rourke; Eric S Rosenthal; Catherine J Chu; M Brandon Westover
Journal:  Seizure       Date:  2014-10-16       Impact factor: 3.184

2.  Robust control of burst suppression for medical coma.

Authors:  M Brandon Westover; Seong-Eun Kim; ShiNung Ching; Patrick L Purdon; Emery N Brown
Journal:  J Neural Eng       Date:  2015-05-28       Impact factor: 5.379

3.  Guidelines for the evaluation and management of status epilepticus.

Authors:  Gretchen M Brophy; Rodney Bell; Jan Claassen; Brian Alldredge; Thomas P Bleck; Tracy Glauser; Suzette M Laroche; James J Riviello; Lori Shutter; Michael R Sperling; David M Treiman; Paul M Vespa
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

4.  Behavioral intoxication following voluntary oral ingestion of tetramethylenedisulfotetramine: Dose-dependent onset, severity, survival, and recovery.

Authors:  Nathaniel C Rice; Noah A Rauscher; Jeffrey L Langston; Todd M Myers
Journal:  Neurotoxicology       Date:  2017-09-07       Impact factor: 4.294

5.  Electroconvulsive therapy for refractory status epilepticus: a case series.

Authors:  Hooman Kamel; Susannah Brock Cornes; Manu Hegde; Stephen E Hall; S Andrew Josephson
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

Review 6.  Neurocritical care update.

Authors:  Yasuhiro Kuroda
Journal:  J Intensive Care       Date:  2016-05-28

7.  The Benefit of Neuromuscular Blockade in Patients with Postanoxic Myoclonus Otherwise Obscuring Continuous Electroencephalography (CEEG).

Authors:  Christopher R Newey; Alejandro Hornik; Meziane Guerch; Anantha Veripuram; Sushma Yerram; Agnieszka Ardelt
Journal:  Crit Care Res Pract       Date:  2017-02-06

8.  Nonconvulsive status epilepticus manifesting as bradyphrenia: a case report.

Authors:  Martijn Weisfelt; Dick van den Wijngaard
Journal:  Cases J       Date:  2009-06-26

9.  Non-convulsive seizures in the encephalopathic critically ill cancer patient does not necessarily portend a poor prognosis.

Authors:  Cristina Gutierrez; Merry Chen; Lei Feng; Sudhakar Tummala
Journal:  J Intensive Care       Date:  2019-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.